Ardelyx (ARDX) Enterprise Value Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.27% |
| Dec 31, 2025 | -5.83% |
| Sep 30, 2025 | -27.47% |
| Jun 30, 2025 | -28.23% |
| Mar 31, 2025 | -5.61% |
| Dec 31, 2024 | -35.70% |
| Sep 30, 2024 | -15.34% |
| Jun 30, 2024 | -45.76% |
| Mar 31, 2024 | -55.38% |
| Dec 31, 2023 | -48.74% |
| Sep 30, 2023 | -82.16% |
| Jun 30, 2023 | -57.48% |
| Mar 31, 2023 | -45.34% |
| Dec 31, 2022 | -6.19% |
| Sep 30, 2022 | 36.02% |
| Jun 30, 2022 | 52.85% |
| Mar 31, 2022 | 49.66% |
| Dec 31, 2021 | 37.43% |
| Sep 30, 2021 | 23.64% |
| Jun 30, 2021 | 16.13% |
| Mar 31, 2021 | 20.16% |
| Dec 31, 2020 | 24.66% |
| Sep 30, 2020 | -79.15% |
| Jun 30, 2020 | -65.27% |
| Mar 31, 2020 | -47.27% |
| Dec 31, 2019 | -47.25% |
| Sep 30, 2019 | 44.45% |
| Jun 30, 2019 | 41.74% |
| Mar 31, 2019 | -18.92% |
| Dec 31, 2018 | -25.46% |
| Sep 30, 2018 | -44.18% |
| Jun 30, 2018 | -43.04% |
| Mar 31, 2018 | 26.51% |
| Dec 31, 2017 | 33.29% |
| Sep 30, 2017 | 43.81% |
| Jun 30, 2017 | -1.40% |
| Mar 31, 2017 | -1.02% |
| Dec 31, 2016 | -87.68% |
| Sep 30, 2016 | -78.30% |
| Jun 30, 2016 | -3.63% |
| Mar 31, 2016 | -74.62% |
| Dec 31, 2015 | 0.26% |
| Sep 30, 2015 | -15.18% |
| Jun 30, 2015 | -20.13% |
| Mar 31, 2015 | -195.95% |
| Dec 31, 2014 | -211.56% |
| Sep 30, 2014 | -376.22% |
| Jun 30, 2014 | -396.08% |